Asymptomatic SARS-CoV2 infection in a patient receiving risankizumab, an inhibitor of interleukin 23

• Madison Ward, BSc, MD,
• Melinda Gooderham, MD, MSc, FRCPC

Affiliations

Madison Ward, BSc, MD

SKiN Centre for Dermatology, Peterborough, Ontario, Canada

Melinda Gooderham, MD, MSc, FRCPC

SKiN Centre for Dermatology, Peterborough, Ontario, Canada; Probity Medical Research, Waterloo, Ontario, Canada; Queen's University, Kingston, Ontario, Canada; Correspondence to: Melinda J. Gooderham, MD, MSc, FRCPC, Skin Centre for Dermatology, 775 Monaghan Road South, Peterborough, ON K9J 5K2, Canada.